In the UK, up to a tenth of the 3,000 research and development workers, who focus on gastrointestinal and heart issues, at AstraZeneca's Alderley Park site in Cheshire will be made redundant.
The nation's second-largest pharmaceutical firm has 61,000 employees worldwide, with 8,000 in the UK. It cut 12,600 positions between 2007 and 2009, with a further 9,000 roles axed by the end of last year. For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
Related Post:
uk stock market
- How payday loan bullies are stealing your cash
- UK stock to watch Invensys, Taylor Wimpey, Vodafone nov 12 2012
- UK Economic out of the double-dip recession report today oct 25 2012
- UK retail sales report september 26 2012
- average payment to a UK bank 2011
- Royal Bank of Scotland shares prices for 8/31/2012
- Lloyds Banking shares prices for 8/31/2012
- London stocks FTSE outlook 8/31/2012
- official figures US economic growth q2 2012
- London stock market closed 8/27/2012
- ETFs Stocks to watch week 27-31 august 2012
- UK Equity markets market closed july 24, 2012
- UK stock market week july 23-27, 2012
- UK Bank Scandals as profits rise, HSBC, Lloyds Banking Group, Royal Bank of Scotland and Barclay
- UK banks need more capital to withstand an escalation in the eurozone crisis
- FTSE 100 stock outlook june 7 2012
- London stock market FTSE 100 down may 23 2012
- impact of Greek exit from Eurozone on UK Economy
- FTSE 100 outlook open may 14 2012
- FTSE stock closed today april 30 2012
- FTSE 100 Risers, Fallers april 26 2012
- Tesco market shares april 2012
- Why Skyepharma stock prices up more than doubled
- FTSE100 expected to open lower today april 23 2012
- British stock market focus next week april 23-27 2012
AstraZeneca
No comments:
Post a Comment